Effects of a beta-lactamase inhibitor, sulbactam, on the activity of carbapenems against Pseudomonas aeruginosa.
Hazumi
N
N
Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd., Japan.
Kato
Y
Y
Hashizume
T
T
Matsuda
K
K
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D015780:Carbapenems / Q000494:pharmacology*; D004357:Drug Synergism; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D015378:Imipenem / Q000494:pharmacology; D000077731:Meropenem; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D013407:Sulbactam / Q000494:pharmacology*; D013845:Thienamycins / Q000494:pharmacology; D065093:beta-Lactamase Inhibitors
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D004791:Enzyme Inhibitors; D013845:Thienamycins; D065093:beta-Lactamase Inhibitors; C085890:BO 2727; D015378:Imipenem; D000077731:Meropenem; D013407:Sulbactam; C039536:panipenem; C065257:biapenem